Early treatment with interferon beta-1a may delay MS onset

Article

Washington, DC-Early treatment of patients at high risk for developing multiple sclerosis (MS), i.e., those with optic neuritis, may be beneficial. The use of interferon beta-1a in these patients at the first sign of optic neuritis or other neurologic symptoms with silent lesions on magnetic resonance imaging (MRI) may significantly delay the development of MS.

Related Videos
This series features 1 KOL.
This series features 1 KOL.
This series features 1 KOL.
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Video 2 - 1 KOL is featured in, "Advances in Technology for SMILE procedure"
© 2024 MJH Life Sciences

All rights reserved.